Calcimimetic Coverage

RSE_Spotlight_Amgen_Jan2021_1424x152.png


2021 Calcimimetic Coverage and Reimbursement Overview
Tuesday, January 19, 2021
1:00 PM - 2:00 PM ET

This presentation will discuss the evolution of the end-stage renal disease (ESRD) bundle, the intent of the Transitional Drug Add-On Payment Adjustment (TDAPA), the valuation and inclusion of calcimimetics as part of the bundle for 2021, and reimbursement beyond the bundle.








Sponsored by:

Amgen-Logo.jpg

About the Presenters

Matthew Bartlett
Director, Nephrology Coverage & Pricing

Matthew Bartlett brings over 25 years of healthcare industry experience with the last 15 years of Nephrology experience with Amgen.  Matthew leads Amgen’s Nephrology Coverage and Pricing team and works closely with Amgen’s Policy team in DC relating on policy and reimbursement issues relating to our Nephrology business.  He has past experience in reimbursement, access, brand leadership, marketing, account management, and sales.



Javier Orozco
Sr. Manager, Nephrology Coverage & Pricing

Javier Orozco brings over 20 years of healthcare industry experience with the last 11 years of Nephrology experience with Amgen. He is currently the Sr. Manager for Nephrology Coverage & Pricing. He has a proven track record of leadership by previously representing the Key Accounts Management, where he had significant Nephrology reimbursement and dialysis customer experience.




* Non-NRAA Members have access to NRAA Education Station (online courses,) but may pay a higher fee per course and are required to register as a Webinar Attendee first. Webinar Attendees do not receive member pricing for courses or any other NRAA Member Benefits.

To join as a NRAA Member or as a Webinar Attendee, click here.